Status:
COMPLETED
Mucormycosis in ICU
Lead Sponsor:
University Hospital, Grenoble
Conditions:
Mucormycosis
Eligibility:
All Genders
18+ years
Brief Summary
Mucormycosis is an invasive fungal infection affecting patients with various clinical conditions especially patients with heavy immunosuppression or patients with trauma or extensive burns. ZygoRéa i...
Detailed Description
Mucormycosis is an invasive fungal infection affecting patients with various clinical conditions especially patients with heavy immunosuppression or patients with trauma or extensive burns. The incide...
Eligibility Criteria
Inclusion
- confirmed or suspected mucormycosis, based on international definition from EORTC/MSG
- patient hospitalized in intensive care unit during the 2008-2016 period
- Zygomycosis identification in at least 2 solids organs or identification in hemoculture
Exclusion
- Age under 18 years old
- Patient under the law
Key Trial Info
Start Date :
September 8 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2018
Estimated Enrollment :
74 Patients enrolled
Trial Details
Trial ID
NCT03387696
Start Date
September 8 2017
End Date
June 1 2018
Last Update
November 8 2022
Active Locations (21)
Enter a location and click search to find clinical trials sorted by distance.
1
Intensive Care Unit - Hospital Amiens
Amiens, France
2
Intensive Care Unit - Hospital Angers
Angers, France
3
Intensive Care Unit - Hospital Besançon
Besançon, France
4
Intensive Care Unit - Hospital Béthune
Béthune, France